ArticleJournal of perinatology : official journal of the California Perinatal Association2026
Multimodal neuromonitoring modalities of neonatal patients on extracorporeal membrane oxygenation.
Article in Journal of perinatology : official journal of the California Perinatal Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo describe the neonatal population requiring ECMO; characterize their neurologic injury; summarize multimodal neuromonitoring (MNM) utilized for neonatal ECMO patients; and discern impacts of MNM on patient management. STUDY
designThis retrospective chart review includes neonates admitted from 2019 to 2023 requiring ECMO. Data include patient characteristics; details of neurologic injury; radiographic, electroencephalogram (EEG), and near-infrared spectroscopy (NIRS) findings; and effects of MNM on patient management.
resultsAmong 53 patients, MNM included head ultrasound (53/53, 100%), continuous EEG (35/53,66%), and NIRS (24/53,45%). The frequency of EEG and NIRS monitoring increased after implementing a MNM protocol. Adverse neurologic events were detected in 18 patients (34%). Responses to MNM findings included change in anticoagulation (12/18,67%), recommending additional neuroimaging (11/18,61%), and anti-seizure medication administration (7/18,39%).
conclusionMNM during ECMO facilitates timely detection of evolving neurologic injury and informs patient management. Utilizing a MNM protocol increased the number of neonates receiving continuous neuromonitoring.
Indexed as
Identifiers
40781152What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.